Two hundred twenty-six patients with bacteremia were prospectively enrolled in a randomized trial that was performed to determine the clinical impact of the receipt of in vitro microbiological data by the physician soon after organism detection as opposed to having the physicians wait until similar data were available by routine methods. Identification and antibiotic susceptibility patterns of 110 isolates were determined by direct inoculation of the Vitek AutoMicrobic system (Vitek Systems, Inç., Hazelwood, Mo.) with a sample from a positive blood culture vial. One hundred sixteen isolates were processed by routine methods. Microbiological results were available within an average of 8.8 h by the direct method yersus an average of 48 h by the routine method. In both groups an infectious disease fellow used the information to make therapeutic recommendations to the responsible physician. When compared with that provided by the routine method, the information provided by the direct method was significantly more likely to result in an initiation of antibiotic therapy, a change to more effective therapy, or a change to less expensive therapy. Recommendations were significantly more likely to be followed in patients whose isolates were processed by the direct method versus the routine method. A projected savings of $158 per patient was estimated for the patients who were changed to less expensive therapy or in whom antibiotics were discontinued because results were available sooner. These cost savings, coupled with changes in therapy made for reasons of efficacy, support the usefulness of the earlier reporting of the identity and antibiotic susceptibility patterns of bacterial blood culture isolates.
Approximately 200,000 cases of septicemia occur annually in the United States, with a 40 to 50% mortality rate (12) . Over the past few years there has been an emphasis in clinical microbiology laboratories to rapidly identify and determine antimicrobial susceptibility patterns of bacterial isolates from blood cultures. It is believed that if this information is provided more rapidly it will result in more timely and cost-effective therapy in hospitalized patients (V. Lorian and D. B. Louria, Editorial, J. Infect. Dis. 142: [661] [662] 1984) . Based on this premise many hospitals have purchased automated or semiautomated systems. While the abilities of many of these systems to produce accurate and rapid results have been studied extensively (3-5, 6, 9-11) , the clinical relevance of the information generated has been less well documented (2) . One such system, the AutoMicrobic system (AMS; Vitek Systems, Inc., Hazelwood, Mo.) . has the ability to identify the organism and determine its antimicrobial susceptibility patterns in 4 to 10 h after the organism is placed in the instrument (1, 6, 8) . Preparation of the organism is usually from a 24-h subculture of a positive blood culture vial. We evaluated a procedure which allows the inoculation of the AMS with bacteria obtained directly from a positive blood culture vial. This allowed identification and antimicrobial susceptibility testing of bacterial blood culture isolates to be completed on the same day that the bacteremia was detected in the clinical microbiology laboratory. Using this system, we analyzed the impact of the receipt of in vitro microbiological data by the physician soon after organism detection on the management of patients with bacteremia in our hospital setting. When a blood culture vial from a patient was confirmed as containing bacteria by Gram staining, an infectious disease fellow contacted the physician responsible for the patient. The fellow explained the purposes and procedures of the study and asked the physician whether the patient could participate in the study. If the patient was allowed to be enrolled in the study, the organism from the patient was randomly assigned to either the routine or the direct method for identification and antimicrobial susceptibility testing. All isolates assigned to the direct method were also processed by the routine method. In both groups, the physician was informed by an infectious disease fellow of the results of the identification and antimicrobial susceptibility test as soon as they were available. For isolates processed by the direct method, this was the same afternoon or evening as the day the blood culture was determined to be positive. For isolates processed by the routine method, this was the morning or afternoon of the day when the identification and susceptibility testing were completed. The infectious disease fellow recommended initiation or alterations in antimicrobial therapy when appropriate. Antimicrobial agents that demonstrated greater clinical efficacy, cost savings, or the potential for less toxicity were recommended. The impact of these recommendations was analyzed with regard to physician compliance and the cost-effective use of antibiotics. RESULTS A total of 226 patients with bacteremia were enrolled in this study; isolates from 110 patients were processed by the were not receiving antibiotics. Recommendations made by the infectious disease fellow were significantly more likely to be followed in the group that was randomized to the direct processing of isolates versus the group that was randomized to the routine processing of isolates. Eighteen patients whose isolates were processed by the direct method were either switched to more effective antibiotic therapy or had antibiotics initiated, compared with only one patient in the routine processing group (P < 0.5). Table 3 lists the categories of noncompliance for the 34 patients in whom the recommendations of the infectious disease fellow were not followed. In the 44 patients who were switched to less expensive therapy or in whom antibiotics were discontinued because results were available sooner, a cost savings of $6,952 was realized. This was based on the projected savings if no change in therapy was made until results were available by the routine method.
DISCUSSION
The conclusion of this study is that earlier is better. By using a modification of the AMS procedure, we were able to provide physicians with either identification or antimicrobial susceptibility results on blood culture isolates within an average of 8.8 h after the blood culture vial was found to be positive. This information was given to the physician responsible for antibiotic therapy by an infectious disease fellow. This means of contact was chosen to increase physician use of the laboratory results. By interposing an infectious disease fellow, we were deliberately biasing the study in favor of maximum compliance. Interestingly, we found a high rate of noncompliance (22.4%) with therapeutic recommenda- 
